Paul Michael Grossman
Affiliation: University of Michigan
- Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesisQinghua Sun
Division of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, Ohio 43210 1252, USA
Pharm Res 27:264-71. 2010....
- Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial diseasePaul Michael Grossman
University of Michigan Healthcare System, Ann Arbor, MI 48109 0311, USA
Am Heart J 153:874-80. 2007....
- Percutaneous coronary intervention complications and guide catheter size: bigger is not betterP Michael Grossman
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan Hospitals and Health System and Veterans Administration Ann Arbor Health System, Ann Arbor, MI 48109 5869, USA
JACC Cardiovasc Interv 2:636-44. 2009..We evaluated the association between guiding catheter size and complications of percutaneous coronary intervention (PCI)...
- Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trialsChristos Kasapis
Division of Cardiovascular Medicine, University of Michigan Health System, Ann Arbor, MI 48109 5853, USA
Eur Heart J 30:44-55. 2009..We performed a meta-analysis of randomized controlled trials comparing routine stenting (ST) with percutaneous transluminal angioplasty (PTA) for symptomatic superficial femoral-popliteal artery (SFPA) disease...